Orthofix Medical Inc. OFIX revenue by segment, product and geography
In its fiscal year ending 2025-12-31, Orthofix Medical Inc. reported revenue across 2 business segments; the largest, Global Spine, was $688M, 83.6% of the filed sum (+1.8% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Global Spine$688M83.6%+1.8% yoy
- Global Limb Reconstruction$135M16.4%+8.4% yoy
Members sum to the consolidated $822M for this period.
- United States$684Mshare n/a+1.7% yoy
- Outside the United States$138Mshare n/a+9.1% yoy
- Other countries$76.7Mshare n/a+15.6% yoy
- Italy$22.3Mshare n/a+6.1% yoy
- United Kingdom$13.3Mshare n/a+19.2% yoy
- France$12Mshare n/a-10.7% yoy
- Germany$9.11Mshare n/a+1.1% yoy
- Brazil$4.84Mshare n/a-15.3% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Global Spine$164M83.3%0.0% yoy
- Global Limb Reconstruction$32.9M16.7%+10.2% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.